Background: The outcomes of patients with heart failure and preserved ejection fraction (HFpEF) have remained largely unchanged. Myocardial transthyretin amyloid deposition (ATTR) has been found in autopsy studies in up… Click to show full abstract
Background: The outcomes of patients with heart failure and preserved ejection fraction (HFpEF) have remained largely unchanged. Myocardial transthyretin amyloid deposition (ATTR) has been found in autopsy studies in up to 30% of patients with HFpEF. The 99mTc-pyrophosphate scintigraphy (PYP) scan
               
Click one of the above tabs to view related content.